Clinical and experimental studies implicate IL-6 in the progression of cancers [11] and CVDs, including hypertension, atherosclerosis, aortic and thoracic aneurysms, cardiac fibrosis, aortic dissection, cardiomyopathy, heart failure, and ischemic stroke [40, 41]. Here, IL6 is linked to atherosclerosis.